Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04564183 · ClinicalTrials.gov registry record
Advancing Prevention of Pulmonary Fibrosis
A clinical trial of Pulmonary Fibrosis and IPF, sponsored by University of Colorado, Denver.
- Active
- Registry status
- 800
- Enrollment target
- 1
- Study location
NCT04564183 is a study of Pulmonary Fibrosis and IPF that is active but no longer recruiting, run by University of Colorado, Denver. The registered enrollment target is 800 participants, roughly in line with the 853-participant average among 22 other Pulmonary Fibrosis trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT04564183, a study of Pulmonary Fibrosis and IPF, is active but no longer recruiting, sponsored by University of Colorado, Denver.
- ACTIVE NOT RECRUITING
- Registry status
- 800 participants
- Enrollment target
- 1
- Study location
Study Summary
This study plans to learn more about pulmonary fibrosis and how it develops. We want to determine if the disease can be detected early, before the lung is permanently scarred. This study will enroll participants who are not currently diagnosed with pulmonary fibrosis, but who have family members with pulmonary fibrosis. Because there is an increased risk within affected families, this cohort will allow us to learn how pulmonary fibrosis develops, and how the lungs change over time.
Conditions Studied
Interventions
- OTHER Questionnaires
- OTHER Sample collection
- DIAGNOSTIC_TEST Pulmonary Function Test
- RADIATION High resolution CT scan of the chest
Study Locations (1)
Colorado
- University of Colorado Anschutz Medical Campus - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2021-01-22 |
| Est. Completion | 2026-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04564183
The ClinicalTrials.gov registry entry for NCT04564183 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 853-participant average among 22 other Pulmonary Fibrosis trials with a reported enrollment target. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Pulmonary Fibrosis appearing as the primary indexed condition, and to 4 interventions - of which Questionnaires is the first listed.
NCT04564183 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT04564183 about?
NCT04564183 is a clinical study titled "Advancing Prevention of Pulmonary Fibrosis". This study plans to learn more about pulmonary fibrosis and how it develops. We want to determine if the disease can be detected early, before the lung is permanently scarred. This study will enroll participants who are not currently diagnosed with pulmonary fibrosis, but who have family members wi...
What is the current status of trial NCT04564183?
This trial is currently active not recruiting. The enrollment target is 800 participants. The study started on 2021-01-22. Estimated completion is 2026-08-01.
What conditions does trial NCT04564183 study?
This clinical trial studies the following conditions: Pulmonary Fibrosis, IPF, ILD.
What interventions are being tested in trial NCT04564183?
The interventions under investigation include: Questionnaires (OTHER), Sample collection (OTHER), Pulmonary Function Test (DIAGNOSTIC_TEST), High resolution CT scan of the chest (RADIATION).
Who is sponsoring clinical trial NCT04564183?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04564183 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Fibrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Advanced Imaging for Pulmonary Fibrosis
RECRUITING · Phase 2
-
Pulmonary Fibrosis Foundation Community Registry
RECRUITING
-
Interstitial Lung Disease Research Unit Biobank
RECRUITING
-
FAPI PET for Lung Fibrosis
RECRUITING · Early Phase 1
-
Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis
RECRUITING
-
Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.